Pretransplantation mogamulizumab for ATLL raises risk of GVHDAugust 23, 2016Aggressive LymphomasT Cell Lymphomas
Mogamulizumab achieves objective responses in relapsed/refractory adult T-cell leukemia-lymphomaJune 10, 2016Aggressive LymphomasT Cell Lymphomas
Alemtuzumab plus CHOP didn’t boost survival in elderly patients with peripheral T-cell lymphomasJune 10, 2016T Cell LymphomasAggressive Lymphomas
Dr. Matt Kalaycio’s top 10 hematologic oncology abstracts for ASCO 2016May 27, 2016CMLAMLCLLT Cell Lymphomas
Peripheral T-cell lymphoma incidence and survival varies significantly by raceJanuary 25, 2016T Cell Lymphomas
Medical Roundtable: Peripheral T-Cell Lymphomas: A Practical Approach to Newly Diagnosed and Relapsed PatientsJanuary 4, 2016T Cell Lymphomas
Topical resiquimod effective for early-stage cutaneous T-cell lymphomaSeptember 24, 2015T Cell Lymphomas
No signal for the superiority of autologous versus allogenic stem-cell transplants in T-cell lymphomaJuly 8, 2015T Cell Lymphomas
